Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells

Experimental Cell Research

Volumn 261, Issue 2, 2000, Pages 348-359

  Maquoi, Erik ^a   Frankenne, Francis ^a   Noël, Agnès ^a   Krell, Hans Willi ^b   Grams, Frank ^b   Foidart, Jean Michel ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; GELATINASE A; HYDROXAMIC ACID; MATRIX METALLOPROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROSARCOMA; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; TRANSCRIPTION REGULATION;

EID: 0034672120     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.5063     Document Type: Article

References (72)

1. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade
2. Loss of basement membrane components by invasive tumors but not by their benign counterparts
3. Tumor invasion and the extracellular matrix
4. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
5. The role of proteolytic enzymes in cancer invasion and metastasis
6. Molecular regulation of cellular invasion-role of gelatinase A and TIMP-2
7. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
8. Progelatinase A activation during tumor cell invasion
9. Activation mechanisms of matrix metalloproteinases
10. Association between the expression of activated 72-kilodalton gelatinase and tumor spread in nonsmall-cell lung carcinoma
11. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts
12. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase-2 (gelatinase A) in human gastric carcinomas
13. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate
14. TNF-α mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology
15. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells
16. Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP)
17. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts: Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of tissue inhibitor of matrix metalloproteinase
18. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72-kDa progelatinase by fibroblast membranes
19. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2
20. Mechanism of cell surface activation of 72-kDa type IV collagenase
21. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines
22. A matrix metalloproteinase expressed on the surface of invasive tumour cells
23. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation
24. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP)
25. Membrane-type matrix metalloproteinase (MT-MMPs) in tumor metastasis
26. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity
27. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor
28. The TIMP-2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A
29. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: Associated activation of gelatinase A, gelatinase B and collagenase 3
30. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP)
31. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes
32. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation
33. Integrins: Versatility, modulation, and signalling in cell adhesion
34. Extracellular matrix 5: Adhesive interactions in early mammalian embryogenesis, implantation, and placentation
35. ECM and cell surface proteolysis: Regulating cellular ecology
36. Biology of tumor cell invasion: Interplay of cell adhesion and matrix degradation
37. Soluble laminin and arginineglycine-aspartic acid containing peptides differentially regulate type IV collagenase messenger RNA, activation, and localization in testicular cell culture
38. Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent
39. Collagen-induced activation of the Mr 72,000 type IV collagenase in normal and malignant human fibroblastoid cells
40. Collagen induced MMP-2 activation in human breast cancer
41. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction
42. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma
43. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton
44. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells
45. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor
46. Characterization of pepsin fragments of basement membrane collagen obtained from a mouse tumor
47. Isolation of fibronectin from plasma and cells
48. The capacity of retracting a collagen matrix is lost by dermatosparactic skin fibroblasts
49. Inhibition of stromal matrix metalloproteinases: Effects on breast tumor progression by fibroblasts
50. Eggs: Conveniently packaged antibodies - Methods for purification of yolk IgG
51. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface
52. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads
53. Membrane type 1-matrix metalloproteinase (MT1-MMP)-associated degradation of tissue inhibitor of metalloproteinase 2 (TIMP-2) in human tumor cell lines
54. Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding
55. Carbohydrate-mediated regulation of matrix metalloproteinase-2 activation in normal human fibroblasts and fibrosarcoma cells
56. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells
57. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro
58. MT1-MMP on the cell surface causes focal degradation of gelatin films
59. Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells
60. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion
61. The activation of proMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa
62. Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex
63. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinase 2
64. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain
65. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2
66. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation
67. Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain
68. Binding of gelatinases A and B to type-I collagen and other matrix components
69. Proteases associated with invadopodia, and their role in degradation of extracellular matrix
70. Cancer invasion and metastasis: Positive and negative regulatory elements
71. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines